Benzinga | Nov 6, 2020 10:34AM EST

SVB Leerink Maintains Outperform on Acceleron Pharma, Raises Price Target to $138

SVB Leerink maintains Acceleron Pharma (NASDAQ:XLRN) with a Outperform and raises the price target from $134 to $138.